{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:30:04Z","timestamp":1792315804324,"version":"4.4.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,2,7]],"date-time":"2010-02-07T00:00:00Z","timestamp":1265500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00520-010-0813-1","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T22:33:27Z","timestamp":1265495607000},"page":"651-655","source":"Crossref","is-referenced-by-count":32,"title":["The treatment of co-morbidities in older patients with metastatic cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"Josephine","family":"Cashman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,7]]},"reference":[{"key":"813_CR1","volume-title":"Cancer: principles and practice of oncology","author":"VT DeVita","year":"2008","unstructured":"DeVita VT, Lawrence TS, Rosenberg SA (2008) Cancer: principles and practice of oncology, 8th edn. Lippincott Williams and Wilkins, Philadelphia","edition":"8"},{"issue":"2","key":"813_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346(2):92\u201398","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"813_CR3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1634\/theoncologist.10-90003-20","volume":"10","author":"J O\u2019Shaughnessy","year":"2005","unstructured":"O\u2019Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10(suppl 3):S20\u2013S29","journal-title":"Oncologist"},{"issue":"7","key":"813_CR4","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/annonc\/mdn058","volume":"19","author":"M Borner","year":"2008","unstructured":"Borner M, Koeberle D, Von Moos R, Saletti P, Rauch D, Hess V et al (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Ann Oncol 19(7):1288\u20131292","journal-title":"Ann Oncol"},{"key":"813_CR5","unstructured":"Cancer Research UK (2008) UK cancer incidence statistics by age. Cited 2009 May 9. http:\/\/info.cancerresearchuk.org\/cancerstats\/incidence\/age\/"},{"issue":"319","key":"813_CR6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/bmj.319.7221.1350","volume":"20","author":"K-T Khaw","year":"1999","unstructured":"Khaw K-T (1999) How many, how old, how soon? BMJ 20(319):1350\u20131352","journal-title":"BMJ"},{"issue":"20","key":"813_CR7","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","volume":"162","author":"JL Wolff","year":"2002","unstructured":"Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269\u20132276","journal-title":"Arch Intern Med"},{"issue":"7471","key":"813_CR8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bmj.329.7471.909","volume":"329","author":"J Stevenson","year":"2004","unstructured":"Stevenson J, Abernethy AP, Miller C, Currow DC (2004) Managing comorbidities in patients at the end of life. BMJ 329(7471):909\u2013912","journal-title":"BMJ"},{"issue":"29","key":"813_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ageing\/29.1.35","volume":"29","author":"CK Mannesse","year":"2000","unstructured":"Mannesse CK, Derkx FHM, De Ridder MAJ, Man in\u2019t Veld AJ, Van der Cammen TJM (2000) Contribution of adverse drug reactions to hospital admissions of older patients. Age Ageing 29(29):35\u201339","journal-title":"Age Ageing"},{"issue":"11","key":"813_CR10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00002512-200320110-00003","volume":"20","author":"V Rollason","year":"2003","unstructured":"Rollason V, Vogt N (2003) Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 20(11):817\u2013832","journal-title":"Drugs Aging"},{"issue":"5","key":"813_CR11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0735-6757(96)90147-3","volume":"14","author":"RM Goldberg","year":"1996","unstructured":"Goldberg RM, Mabee J, Chan L, Wong S (1996) Drug\u2013drug and drug\u2013disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 14(5):447\u2013450","journal-title":"Am J Emerg Med"},{"issue":"1","key":"813_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/tcrm.1.1.39.53597","volume":"1","author":"Y Koh","year":"2005","unstructured":"Koh Y, Kutty FB, Li SC (2005) Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 1(1):39\u201348","journal-title":"Ther Clin Risk Manag"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-010-0813-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0813-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:57Z","timestamp":1559095317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-010-0813-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,7]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1007\/s00520-010-0813-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,7]]}}}